Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5273308
Max Phase: Preclinical
Molecular Formula: C18H20O4
Molecular Weight: 300.35
Associated Items:
ID: ALA5273308
Max Phase: Preclinical
Molecular Formula: C18H20O4
Molecular Weight: 300.35
Associated Items:
Canonical SMILES: C[C@@H]1Cc2cc(O)c(O)cc2-c2cc(O)c(O)cc2C[C@@H]1C
Standard InChI: InChI=1S/C18H20O4/c1-9-3-11-5-15(19)17(21)7-13(11)14-8-18(22)16(20)6-12(14)4-10(9)2/h5-10,19-22H,3-4H2,1-2H3/t9-,10+
Standard InChI Key: QAIDKUGAYKKTCT-AOOOYVTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.35 | Molecular Weight (Monoisotopic): 300.1362 | AlogP: 3.55 | #Rotatable Bonds: 0 |
Polar Surface Area: 80.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.09 | CX Basic pKa: | CX LogP: 4.43 | CX LogD: 4.42 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.56 | Np Likeness Score: 0.97 |
1. Bernardes G, Munir O, Krol ES.. (2023) The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro., 78 [PMID:36587551] [10.1016/j.bmc.2022.117147] |
Source(1):